A hypertension gene: Are we there yet?

Twin Research and Human Genetics

Volumn 14, Issue 4, 2011, Pages 295-304

  Lupton, Samantha J ^a   Chiu, Christine L ^a   Lind, Joanne M ^a  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Association studies; Blood pressure; Genetics; Hypertension; Pharmacogenomics

Indexed keywords

ADDUCIN; ADRA2A PROTEIN; ALDOSTERONE SYNTHASE; ALPHA 1A ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHYMASE; CHYMASE 1; DEBRISOQUINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; IRBESARTAN; LEP PROTEIN; LEPR PROTEIN; MINERALOCORTICOID RECEPTOR; PROSTAGLANDIN E RECEPTOR 3; RENIN; SLC4A1 PROTEIN; SLC4A2 PROTEIN; SLC8A1 PROTEIN; STEROID 11BETA MONOOXYGENASE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG SAFETY; ESSENTIAL HYPERTENSION; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; HYPERTENSION; MONOGENIC DISORDER; MONOTHERAPY; PHARMACODYNAMICS; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

ANTIHYPERTENSIVE AGENTS; GENES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 80051522328     PISSN: 18324274     EISSN: None     Source Type: Journal    
DOI: 10.1375/twin.14.4.295     Document Type: Review

References (85)

1. Acuna, R., Martinez-de-la-Maza, L., Ponce-Coria, J., Vazquez, N., Ortal-Vite, P., Pacheco-Alvarez, D., Bobadilla, N. A., & Gamba, G. (2011). Rare mutations in SLC12A1 and SLC12A3 protect against hypertension by reducing the activity of renal salt cotransporters. Journal of Hypertension, 29, 475-483.
2. Adeyemo, A., Gerry, N., Chen, G., Herbert, A., Doumatey, A., Huang, H., Zhou, J., Lashley, K., Chen, Y., Christman, M., & Rotimi, C. (2009). A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genetics, 5, e1000564.
3. Asai, T., Ohkubo, T., Katsuya, T., Higaki, J., Fu, Y., Fukuda, M., Hozawa, A., Matsubara, M., Kitaoka, H., Tsuji, I., Araki, T., Satoh, H., Hisamichi, S., Imai, Y., & Ogihara, T. (2001). Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: The Ohasama Study. Hypertension, 38, 1321-1324. (Pubitemid 34033410)
4. Benetos, A., Gautier, S., Ricard, S., Topouchian, J., Asmar, R., Poirier, O., Larosa, E., Guize, L., Safar, M., Soubrier, F., & Cambien, F. (1996). Influence of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation, 94, 698-703. (Pubitemid 26289224)
5. Benjafield, A. V., Katyk, K., & Morris, B. J. (2003). Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension. Clinical Genetics, 64, 433-438. (Pubitemid 37406894)
6. Bloem, L. J., Manatunga, A. K., Tewksbury, D. A., & Pratt, J. H. (1995). The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. Journal of Clinical Investigation, 95, 948-953.
7. Bonnardeaux, A., Davies, E., Jeunemaitre, X., Fery, I., Charru, A., Clauser, E., Tiret, L., Cambien, F., Corvol, P., & Soubrier, F. (1994). Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension, 24, 63-69. (Pubitemid 24195405)
8. Cabadak, H., Orun, O., Nacar, C., Dogan, Y., Guneysel, O., Fak, A. S., & Kan, B. (2011). The Role of G Protein beta3 Subunit Polymorphisms C825T, C1429T, and G5177A in Turkish Subjects with Essential Hypertension. Clinical and Experimental Hypertension, 33, 202-208.
9. Carratero, O. A. (2005). Novel mechanism of action of ACE and its inhibitors. American Journal of Heart and Circulatory Physiology, 289, 1796-1797.
10. Cheng, X., & Xu, G. (2009). Association between aldosterone synthase CYP11B2 polymorphism and essential hypertension in Chinese: A meta-analysis. Kidney and Blood Pressure Research, 32, 128-140.
11. Conen, D., Cheng, S., Steiner, L. L., Buring, J. E., Ridker, P. M., & Zee, R. Y. (2009). Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: The Women's Genome Health Study. Journal of Hypertension, 27, 476-483.
12. Cui, J., Zhou, X., Chazaro, I., DeStefano, A. L., Manolis, A. J., Baldwin, C. T., & Gavras, H. (2003). Association of polymorphisms in the promoter region of the PNMT gene with essential hypertension in African Americans but not in whites. American Journal of Hypertension, 16, 859-863. (Pubitemid 37204684)
13. Davis, G. K., & Roberts, D. H. (1997). Molecular genetics of the renin-angiotensin system: implications for angiotensin II receptor blockade. Pharmacology & Therapeutics, 75, 43-50. (Pubitemid 27444686)
14. Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., & Stevenson, W. (2006). The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes: Part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation, 114, 2850-2870. (Pubitemid 46018288)
15. Ehret, G. B., Morrison, A. C., O'Connor, A. A., Grove, M. L., Baird, L., Schwander, K., Weder, A., Cooper, R. S., Rao, D. C., Hunt, S. C., Boerwinkle, E., & Chakravarti, A. (2008). Replication of the Wellcome Trust genome-wide association study of essential hypertension: The Family Blood Pressure Program. European Journal of Human Genetics, 16, 1507-1511.
16. Facemire, C. S., Nixon, A. B., Griffiths, R., Hurwitz, H., & Coffman, T. M. (2009). Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension, 54, 652-658.
17. Fan, X., Wang, Y., Sun, K., Zhang, W., Yang, X., Wang, S., Zhen, Y., Wang, J., Li, W., Han, Y., Liu, T., Wang, X., Chen, J., Wu, H., & Hui, R. (2007). Polymorphisms of ACE2 gene are associated with essential hypertension and anti-hypertensive effects of Captopril in women. Clinical Pharmacology and Therapeutics, 82, 187-196. (Pubitemid 47075335)
18. Franceschini, N., Reiner, A. P., & Heiss, G. (2011). Recent findings in the genetics of blood pressure and hypertension traits. American Journal of Hypertension, 24, 392-400.
19. Fu, Z., Nakayama, T., Sato, N., Izumi, Y., Kasamaki, Y., Shindo, A., Ohta, M., Soma, M., Aoi, N., Sato, M., Ozawa, Y., & Ma, Y. (2008). A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men. Journal of Hypertension, 26, 453-461. (Pubitemid 351320499)
20. Gonzalez, F. J., Skoda, R. C., Kimura, S., Umeno, M., Zanger, U. M., Nebert, D. W., Gelboin, H. V., Hardwick, J. P., & Meyer, U. A. (1988). Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature, 331, 442-446. (Pubitemid 18064368)
21. Gu, D., Ge, D., Snieder, H., He, J., Chen, S., Huang, J., Li, B., Chen, R., & Qiang, B. (2006). Association of alpha1A adrenergic receptor gene variants on chromosome 8p21 with human stage 2 hypertension. Journal of Hypertension, 24, 1049-1056. (Pubitemid 43772312)
22. Gu, D., Su, S., Ge, D., Chen, S., Huang, J., Li, B., Chen, R., & Qiang, B. (2006). Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension, 47, 1147-1154. (Pubitemid 44289172)
23. Hingorani, A. D., Jia, H., Stevens, P. A., Hopper, R., Dickerson, J. E., & Brown, M. J. (1995). Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. Journal of Hypertension, 13, 1602-1609. (Pubitemid 26015783)
24. Ho, J. E., Levy, D., Rose, L., Johnson, A. D., Ridker, P. M., & Chasman, D. I. (2011). Discovery and replication of novel blood pressure genetic loci in the Women's Genome Health Study. Journal of Hypertension, 29, 62-69.
25. Hong, K. W., Jin, H. S., Lim, J. E., Kim, S., Go, M. J., & Oh, B. (2010). Recapitulation of two genomewide association studies on blood pressure and essential hypertension in the Korean population. Journal of Human Genetics, 55, 336-341
26. Jachymova, M., Horky, K., Bultas, J., Kozich, V., Jindra, A., Peleska, J., & Martasek, P. (2001). Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochemical and Biophysical Research Communications, 284, 426-430. (Pubitemid 32917993)
27. Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., & Lalouel, J. M. (1992). Molecular basis of human hypertension: Role of angiotensinogen. Cell, 71, 169-180.
28. Jiang, Z., Zhao, W., Yu, F., & Xu, G. (2001). Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Chinese Medical Journal (English), 114, 1249-1251. (Pubitemid 34041492)
29. Johnson, J. A., Boerwinkle, E., Zineh, I., Chapman, A. B., Bailey, K., Cooper-DeHoff, R. M., Gums, J., Curry, R. W., Gong, Y., Beitelshees, A. L., Schwartz, G., & Turner, S. T. (2009). Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study. American Heart Journal, 157, 442-449.
30. Kamide, K., Kokubo, Y., Fukuhara, S., Hanada, H., Yang, J., Kada, A., Nagura, J., Takiuchi, S., Horio, T., Kawano, Y., Okayama, A., Tomoike, H., & Miyata, T. (2007). Protein tyrosine kinase 2β as a candidate gene for hypertension. Pharmacogenetics and Genomics, 17, 931-939. (Pubitemid 350293793)
31. Kamide, K., Kokubo, Y., Yang, J., Matayoshi, T., Inamoto, N., Takiuchi, S., Horio, T., Miwa, Y., Yoshii, M., Tomoike, H., Tanaka, C., Banno, M., Okuda, T., Kawano, Y., & Miyata, T. (2007). Association of genetic polymorphisms of ACADSB and COMT with human hypertension. Journal of Hypertension, 25, 103-110. (Pubitemid 44885670)
32. Keavney, B., Mayosi, B., Gaukrodger, N., Imrie, H., Baker, M., Fraser, R., Ingram, M., Watkins, H., Farrall, M., Davies, E., & Connell, J. (2005). Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. Journal of Clinical Endocrinology and Metabolism, 90, 1072-1077. (Pubitemid 40279236)
33. Kosuge, K., Soma, M., Nakayama, T., Aoi, N., Sato, M., Izumi, Y., & Matsumoto, K. (2007). A novel variable number of tandem repeat of the natriuretic peptide precursor B gene's 5′-flanking region is associated with essential hypertension among Japanese females. International Journal of Medical Sciences, 4, 146-152. (Pubitemid 46795182)
34. Kurland, L., Melhus, H., Karlsson, J., Kahan, T., Malmqvist, K., Ohman, K. P., Nystrom, F., Hagg, A., Lind, L., & Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol, T. (2001). Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients. Journal of Hypertension, 19, 1783-1787. (Pubitemid 32924944)
35. Levy, D., Ehret, G., Rice, K., Verwoert, G. C., Launer, L. J., Dehghan, A., Glazer, N. L., Morrison, A. C., Johnson, A. D., Aspelund, T., Aulchenko, Y., Lumley, T., Köttgen, A., Vasan, R. S., Rivadeneira, F., Eiriksdottir, G., Guo, X., Arking, D. E., Mitchell, G. F., Mattace-Raso, F. U., Smith, A. V., Taylor, K., Scharpf, R. B., Hwang, S. J., Bis, J., Harris, T. B., Ganesh, S. K., O'Donnell, C. J., Hofman, A., Rotter, J. I., Coresh, J., Benjamin, E. J., Uitterlinden, A. G., Heiss, G., Fox, C. S., Witteman, J. C., Boerwinkle, E., Wang, T. J., Gudnason, V., Larson, M. G., Chakravarti, A., Psaty, B. M., & van Duijn, C. M. (2009). Genome-wide association study of blood pressure and hypertension. Nature Genetics, 41, 677-687.
36. Lewington, S., Clarke, R., Qizilbash, N., Peto, R., Collins, R., & Prospective Studies, C. (2002). Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. [Erratum appears in Lancet. 2003 Mar 22;361(9362):1060]. Lancet, 360, 1903-1913. (Pubitemid 35472129)
37. Lin, R., Fu, W., Zhou, W., Wang, Y., Wang, X., Huang, W., & Jin, L. (2011). Association of heme oxygenase-1 gene polymorphisms with essential hypertension and blood pressure in the Chinese Han population. Genetic Testing and Molecular Biomarkers, 15, 23-28.
38. Lou, Y., Liu, J., Li, Y., Liu, Y., Wang, Z., Liu, K., Wu, H., Niu, Q., Gu, W., Guo, Y., Li, Z., & Wen, S. (2011). Association Study of the beta2-Adrenergic Receptor Gene Polymorphisms and Hypertension in the Northern Han Chinese. PLoS One, 6, e18590.
39. Ma, J., & Stafford, R. S. (2008). Screening, treatment, and control of hypertension in US private physician offices, 2003-2004. Hypertension, 51, 1275-1281. (Pubitemid 351555937)
40. Mahgoub, A., Idle, J. R., Dring, L. G., Lancaster, R., & Smith, R. L. (1977). Polymorphic hydroxylation of Debrisoquine in man. Lancet, 2, 584-586. (Pubitemid 8176607)
41. Mashimo, Y., Suzuki, Y., Hatori, K., Tabara, Y., Miki, T., Tokunaga, K., Katsuya, T., Ogihara, T., Yamada, M., Takahashi, N., Makita, Y., Nakayama, T., Soma, M., Hirawa, N., Umemura, S., Ohkubo, T., Imai, Y., & Hata, A. (2008). Association of TNFRSF4 gene polymorphisms with essential hypertension. Journal of Hypertension, 26, 902-913. (Pubitemid 351520977)
42. Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M. D., Bochud, M., Coin, L., Najjar, S. S., Zhao, J., et al. (2009). Genome-wide association study identifies eight loci associated with blood pressure. Nature Genetics, 41, 666-676.
43. O'Donnell, C. J., Lindpaintner, K., Larson, M. G., Rao, V. S., Ordovas, J. M., Schaefer, E. J., Myers, R. H., & Levy, D. (1998). Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation, 97, 1766-1772.
44. Oparil, S., & Haber, E. (1974a). The renin-angiotensin system (first of two parts). New England Journal of Medicine, 291, 389-401.
45. Oparil, S., & Haber, E. (1974b). The renin-angiotensin system (second of two parts). New England Journal of Medicine, 291, 446-457.
46. Org, E., Eyheramendy, S., Juhanson, P., Gieger, C., Lichtner, P., Klopp, N., Veldre, G., Döring, A., Viigimaa, M., So&tild;ber, S., Tomberg, K., Eckstein, G., Kelgo, P., Rebane, T., Shaw-Hawkins, S., Howard, P., Onipinla, A., Dobson, R. J., Newhouse, S. J., Brown, M., Dominiczak, A., Connell, J., Samani, N., Farrall, M., Caulfield, M. J., Munroe, P. B., Illig, T., Wichmann, H. E., Meitinger, T., & Laan, M. (2009). Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Human Molecular Genetics, 18, 2288-2296.
47. Putku, M., Kepp, K., Org, E., Sober, S., Comas, D., Viigimaa, M., Veldre, G., Juhanson, P., Hallast, P., Tonisson, N., Shaw-Hawkins, S., Caulfield, M. J., Khusnutdinova, E., Kozich, V., Munroe, P. B., & Laan, M. (2011). Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans. Human Mutation (in press).
48. Quintana, L. F., Guzman, B., Collado, S., Claria, J., & Poch, E. (2006). A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE. Kidney International, 69, 526-530. (Pubitemid 43164445)
49. Reckelhoff, J. F. (2000). Gender Differences in the Regulation of Blood Pressure. Hypertension, 37, 1199-1208.
50. Riddle, E. L., Rana, B. K., Murthy, K. K., Rao, F., Eskin, E., O'Connor, D. T., & Insel, P. A. (2006). Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives. Hypertension, 47, 415-420. (Pubitemid 43740284)
51. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variation of serum enzyme levels. Journal of Clinical Investigation, 86, 1343-1346. (Pubitemid 20370444)
52. Rodriguez-Perez, J. C., Rodriguez-Esparragon, F., Hernandez-Perera, O., Anabitarte, A., Losada, A., Medina, A., Hernandez, E., Fiuza, D., Avalos, O., Yunis, C., & Ferrario, C. M. (2001). Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: The PROCAGENE study. Prospective Cardiac Gene. Journal of the American College of Cardiology, 37, 1536-1542.
53. Schmidt, S., van Hooft, I. M., Grobbee, D. E., Ganten, D., & Ritz, E. (1993). Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. Journal of Hypertension, 11, 345-348. (Pubitemid 23139775)
54. Shimodaira, M., Nakayama, T., Sato, N., Aoi, N., Sato, M., Izumi, Y., Soma, M., & Matsumoto, K. (2010). Association of HSD3B1 and HSD3B2 gene polymorphisms with essential hypertension, aldosterone level, and left ventricular structure. European Journal of Endocrinology, 163, 671-680.
55. Shimodaira, M., Nakayama, T., Sato, N., Naganuma, T., Yamaguchi, M., Aoi, N., Sato, M., Izumi, Y., Soma, M., & Matsumoto, K. (2010). Association study of the elastin microfibril interfacer 1 (EMILIN1) gene in essential hypertension. American Journal of Hypertension, 23, 547-555.
56. Shimodaira, M., Nakayama, T., Sato, N., Saito, K., Morita, A., Sato, I., Takahashi, T., Soma, M., & Izumi, Y. (2008). Association study of aromatase gene (CYP19A1) in essential hypertension. International Journal of Medical Sciences, 5, 29-35.
57. Sober, S., Org, E., Kepp, K., Juhanson, P., Eyheramendy, S., Gieger, C., Lichtner, P., Klopp, N., Veldre, G., Viigimaa, M., Doring, A., Putku, M., Kelgo, P., Shaw-Hawkins, S., Howard, P., Onipinla, A., Dobson, R. J., Newhouse, S. J., Brown, M., Dominiczak, A., Connell, J., Samani, N., Farrall, M., Caulfield, M. J., Munroe, P. B., Illig, T., Wichmann, H. E., Meitinger, T., & Laan, M. (2009). Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array. PLoS One, 4, e6034.
58. Song, S. B., Jin, H. S., Hong, K. W., Lim, J. E., Moon, J. Y., Jeong, K. H., Ihm, C. G., Lee, T. W., Oh, B., & Lee, S. H. (2011). Association between renin-angiotensin-aldosterone system-related genes and blood pressure in a Korean population. Blood Pressure, February 23, [Epub ahead of print].
59. Sun, B., Williams, J. S., Pojoga, L., Chamarthi, B., Lasky-Su, J., Raby, B. A., Hopkins, P. N., Jeunemaitre, X., Brown, N. J., Ferri, C., & Williams, G. H. (2011). Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses. Journal of Renin Angiotensin-Aldosterone System.
60. Sun, Z. J., Li, Y., Lu, J. Y., Ding, Q., Liang, Y., Shi, J. P., Li-Ling, J., & Zhao, Y. Y. (2009). Association of Ala589Ser polymorphism of WNK4 gene with essential hypertension in a high-risk Chinese population. Journal of Physiological Sciences, 59, 81-86.
61. Takeuchi, F., Isono, M., Katsuya, T., Yamamoto, K., Yokota, M., Sugiyama, T., Nabika, T., Fujioka, A., Ohnaka, K., Asano, H., Yamori, Y., Yamaguchi, S., Kobayashi, S., Takayanagi, R., Ogihara, T., & Kato, N. (2010). Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation, 121, 2302-2309.
62. Tamaki, S., Nakamura, Y., Tsujita, Y., Nozaki, A., Amamoto, K., Kadowaki, T., Kita, Y., Okamura, T., Iwai, N., Kinoshita, M., & Ueshima, H. (2002). Polymorphism of the angiotensin converting enzyme gene and blood pressure in a Japanese general population (the Shigaraki Study). Hypertension Research, 25, 843-848. (Pubitemid 36024639)
63. Timasheva, Y. R., Nasibullin, T. R., Zakirova, A. N., & Mustafina, O. E. (2008). Association of interleukin-6, interleukin-12, and interleukin-10 gene polymorphisms with essential hypertension in Tatars from Russia. Biochemical Genetics, 46, 64-74.
64. Tobin, M. D., Tomaszewski, M., Braund, P. S., Hajat, C., Raleigh, S. M., Palmer, T. M., Caulfield, M., Burton, P. R., & Samani, N. J. (2008). Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population. Hypertension, 51, 1658-1664.
65. Turner, S. T., Schwartz, G. L., Chapman, A. B., & Boerwinkle, E. (2001). C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension, 37, 739-743. (Pubitemid 32199059)
66. Ueno, T., Soma, M., Tabara, Y., Tokunaga, K., Tahira, K., Fukuda, N., Matsumoto, K., Nakayama, T., Katsuya, T., Ogihara, T., Makita, Y., Hata, A., Yamada, M., Takahashi, N., Hirawa, N., Umemura, S., & Miki, T. (2008). Association between fatty acid binding protein 3 gene variants and essential hypertension in humans. American Journal of Hypertension, 21, 691-695. (Pubitemid 351733382)
67. Ueno, T., Tabara, Y., Fukuda, N., Tahira, K., Matsumoto, T., Kosuge, K., Haketa, A., Matsumoto, K., Sato, Y., Nakayama, T., Katsuya, T., Ogihara, T., Makita, Y., Hata, A., Yamada, M., Takahashi, N., Hirawa, N., Umemura, S., Miki, T., & Soma, M. (2009). Association of SLC6A9 gene variants with human essential hypertension. Journal of Atherosclerosis and Thrombosis, 16, 201-206.
68. Vassilikioti, S., Doumas, M., Douma, S., Petidis, K., Karagiannis, A., Balaska, K., Vyzantiadis, A., & Zamboulis, C. (1996). Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Journal of Hypertension, 9, 700-702. (Pubitemid 26266610)
69. Wang, J. G., Staessen, J. A., Barlassina, C., Fagard, R., Kuznetsova, T., Struijker-Boudier, H. A., Zagato, L., Citterio, L., Messaggio, E., & Bianchi, G. (2002). Association between hypertension and variation in the alpha- and beta-adducin genes in a white population. Kidney International, 62, 2152-2159. (Pubitemid 35366170)
70. Wang, Y., O'Connell, J. R., McArdle, P. F., Wade, J. B., Dorff, S. E., Shah, S. J., Shi, X., Pan, L., Rampersaud, E., Shen, H., Kim, J. D., Subramanya, A. R., Steinle, N. I., Parsa, A., Ober, C. C., Welling, P. A., Chakravarti, A., Weder, A. B., Cooper, R. S., Mitchell, B. D., Shuldiner, A. R., & Chang, Y. P. (2009). From the cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proceedings of the National Academy of Sciences of the United States of America, 106, 226-221.
71. Weber, W. (1997). Human drug-metabolizing enzyme variants. In M. Borrow, P. Harper, A. Motulsky & C. Scriver (Eds.), Pharmacogenetics (1st ed., pp. 131-216). New York: Oxford University Press.
72. Whitworth, J. A. (2003). Emerging drugs in the management of hypertension. Expert Opinion on Emerging Drugs, 8, 377-388.
73. Williams, S. S. (2007). Advances in genetic hypertension. Current Opinion in Pediatrics, 19, 192-198.
74. Wilson, F., Disse-Nicodeme, S., Choate, K., Ishikawa, K., Nelson-Williams, C., Desitter, I., Gunel, M., Milford, D., Lipkin, G., Achard, J., Feely, M., Dussol, B., Berland, Y., Unwin, R., Mayan, H., Simon, D., Farfel, Z., Jeunemaitre, X., & Lifton, R. (2001). Human hypertension caused by mutations in wnk kinases. Science, 293, 1107-1112. (Pubitemid 32758085)
75. Wong, T. Y., & Mitchell, P. (2007). The eye in hypertension [Research Support, N.I.H., Extramural Research Support, Non-U.S. Government Review]. Lancet, 369, 425-435.
76. World Health Organization, (2011). Cardiovascular disease. Retrieved from http://www.who.int/mediacentre/factsheets/fs317/en/index.html
77. Welcome Trust Case Control Consortium (WTCCC). (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.
78. Wu, S. N., Zhang, Y., Gardner, C. O., Chen, Q., Li, Y., Wang, G. L., Gao, P. J., & Zhu, D. L. (2007). Evidence for association of polymorphisms in CYP2J2 and susceptibility to essential hypertension. Annals of Human Genetics, 71, 519-525. (Pubitemid 46865499)
79. Yan-Yan, L. (2011). Transforming growth factor beta1 +869T/C gene polymorphism and essential hypertension: A meta-analysis involving 2708 participants in the Chinese population. Internal Medicine, 50, 1089-1092.
80. Yang, H. C., Liang, Y. J., Wu, Y. L., Chung, C. M., Chiang, K. M., Ho, H. Y., Ting, C. T., Lin, T. H., Sheu, S. H., Tsai, W. C., Chen, J. H., Leu, H. B., Yin, W. H., Chiu, T. Y., Chen, C. I., Fann, C. S., Wu, J. Y., Lin, T. N., Lin, S. J., Chen, Y. T., Chen, J. W., & Pan, W. H. (2009). Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan. PLoS One, 4, e5459.
81. Yi, L., Gu, Y. H., Wang, X. L., An, L. Z., Xie, X. D., Shao, W., Ma, L. Y., Fang, J. R., An, Y. D., Wang, F., & Zhang, D. L. (2006). Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. The Journal of International Medical Research, 34, 272-283. (Pubitemid 44057270)
82. Zee, R. Y., Lou, Y. K., Griffiths, L. R., & Morris, B. J. (1992). Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochemical and Biophysical Research Communications, 184, 9-15.
83. Zhao, Q., Fan, Z., He, J., Chen, S., Li, H., Zhang, P., Wang, L., Hu, D., Huang, J., Qiang, B., & Gu, D. (2007). Renalase gene is a novel susceptibility gene for essential hypertension: A two-stage association study in northern Han Chinese population. Journal of Molecular Medicine, 85, 877-885. (Pubitemid 47077106)
84. Zhao, W., Wang, Y., Wang, L., Lu, X., Yang, W., Huang, J., Chen, S., & Gu, D. (2009). Gender-specific association between the kininogen 1 gene variants and essential hypertension in Chinese Han population. Journal of Hypertension, 27, 484-490.
85. Zhou, X. F., Cui, J., DeStefano, A. L., Chazaro, I., Farrer, L. A., Manolis, A. J., Gavras, H., & Baldwin, C. T. (2005). Polymorphisms in the promoter region of catalase gene and essential hypertension. Disease Markers, 21, 3-7. (Pubitemid 40387204)